Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Mouse monoclonal antibody

Anti-Procollagen type I C-terminal propeptide (human, PICP)

CAT NO: BTE 002-08 | Application: ELISA, IP


Cat. No.

BTE 002-08

Specificity

BTE 002-08 is specific for for native PICP from amniotic fluid.

Immunogen

PICP purified from second trimester amniotic fluid by affinity chromatography

Host

Mouse

Positive Species Reactivity

Human

Negative Species Reactivity

Not determined

Isotype

IgG1/k

Gene ID

1277

Clone Number

8

Epitope Specificity

Epitope differs from that of BTE 002-18

Unit Size

400 µL: Cat. No. BTE 002-08-04 1 mL: Cat. No. BTE 002-08-1 1 mg/mL +/- 15%. See Certificate of Analysis for details.

Purification

protein A/G purified (from culture supernatant)

Form

Liquid

Solvent

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

Conjugation

Unconjugated BSA free

Storage

4-8ºC without exposure to light. No precautions necessary during handling.

Target

Collagen type I is present in soft connective tissue and bone where it represents approximately 90% of the organix matrix. Collagen type I is produced from procollagen when two teloterminal propeptides are digested from the procursor and released into the circulation. The propeptide levels can be measured in serum as indicators of collagen production. Elevated values of these propeptides in serum are found in patients with various bone metabolism defects. Procollagen type I C-terminal propeptide (PICP) has a molecular weight of approximately 100 kDa and the normal range in serum is 100-300μg/ml.